Endocross Device
Payments companies reported to CMS as associated with Endocross Device. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Endocross Device, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Endocross Device
These are the largest totals companies reported as associated with Endocross Device. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| John Park | Omaha, NE | Vascular Surgery | $84,142.69 |
| Venkatesh Ramaiah | Scottsdale, AZ | Vascular Surgery | $57,034.08 |
| James Joye | Mountain View, CA | Interventional Cardiology | $42,178.99 |
| Christopher Busken | Live Oak, TX | Vascular Surgery | $32,202.09 |
| Vincent Digiovanni | Media, PA | Vascular Surgery | $32,002.39 |
| Jaafer Golzar | Oak Lawn, IL | Interventional Cardiology | $27,681.90 |
| Sean Lyden | Cleveland, OH | Vascular Surgery | $25,097.06 |
| Heath Broussard | Jackson, TN | Surgery | $17,794.56 |
| Peter Schneider | Honolulu, HI | Vascular Surgery | $17,750.00 |
| Harvey Garrett | Memphis, TN | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $16,978.76 |
Prescribed Endocross Device?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.